|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xu W, Yang Z and Lu N: Molecular targeted
therapy for the treatment of gastric cancer. J Exp Clin Cancer Res.
35:12016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dolcetti R, De Re V and Canzonieri V:
Immunotherapy for gastric cancer: Time for a personalized approach?
Int J Mol Sci. 19:E16022018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Su M, Xiao Y, Ma J, Tang Y, Tian B, Zhang
Y, Li X, Wu Z, Yang D, Zhou Y, et al: Circular RNAs in Cancer:
Emerging functions in hallmarks, stemness, resistance and roles as
potential biomarkers. Mol Cancer. 18:902019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Memczak S, Jens M, Elefsinioti A, Torti F,
Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer
M, et al: Circular RNAs are a large class of animal RNAs with
regulatory potency. Nature. 495:333–338. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cheng J, Zhuo H, Xu M, Wang L, Xu H, Peng
J, Hou J, Lin L and Cai J: Regulatory network of circRNA-miRNA-mRNA
contributes to the histological classification and disease
progression in gastric cancer. J Transl Med. 16:2162018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yu J, Yang M, Zhou B, Luo J, Zhang Z,
Zhang W and Yan Z: CircRNA-104718 acts as competing endogenous RNA
and promotes hepatocellular carcinoma progression through
microRNA-218-5p/TXNDC5 signaling pathway. Clin Science (Lond.).
133:1487–1503. 2019. View Article : Google Scholar
|
|
10
|
Luan W, Shi Y, Zhou Z, Xia Y and Wang J:
circRNA_0084043 promote malignant melanoma progression via
miR-153-3p/Snail axis. Biochem Biophys Res Commun. 502:22–29. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li X, Lin S, Mo Z, Jiang J, Tang H, Wu C
and Song J: CircRNA_100395 inhibits cell proliferation and
metastasis in ovarian cancer via regulating
miR-1228/p53/epithelial-mesenchymal transition (EMT) axis. J
Cancer. 11:599–609. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen Q, Chen Z, Cao S, Guo B, Chen Y, Feng
Z, Wang J, Guo G, Chen X and Huang X: Role of CircRNAs_100395 in
proliferation and metastases of liver cancer. Med Sci Monit.
25:6181–6192. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen D, Ma W, Ke Z and Xie F: CircRNA
hsa_circ_100395 regulates miR-1228/TCF21 pathway to inhibit lung
cancer progression. Cell Cycle. 17:2080–2090. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Feng W, Li B, Wang J, Zhang H, Liu Y, Xu
D, Cheng K and Zhuang J: Long Non-coding RNA LINC00115 contributes
to the progression of colorectal cancer by targeting miR-489-3p via
the PI3K/AKT/mTOR pathway. Front Genet. 11:5676302020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hu M, Zhu S, Xiong S, Xue X and Zhou X:
MicroRNAs and the PTEN/PI3K/Akt pathway in gastric cancer (Review).
Oncol Rep. 41:1439–1454. 2019.PubMed/NCBI
|
|
17
|
Huang Y, Zhang J, Hou L, Wang G, Liu H,
Zhang R, Chen X and Zhu J: LncRNA AK023391 promotes tumorigenesis
and invasion of gastric cancer through activation of the PI3K/Akt
signaling pathway. J Exp Clin Cancer Res. 36:1942017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu L, Chen J, Jia L, Chen X, Awaleh Moumin
F and Cai J: SLC1A3 promotes gastric cancer progression via the
PI3K/AKT signalling pathway. J Cell Mol Med. 24:14392–14404. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yu J, Huang C, Sun Y, Su X, Cao H, Hu J,
Wang K, Suo J, Tao K, He X, et al Chinese laparoscopic
gastrointestinal surgery study (CLASS) group, : Effect of
laparoscopic vs. open distal gastrectomy on 3-year disease-free
survival in patients with locally advanced gastric cancer: The
CLASS-01 randomized clinical trial. JAMA. 321:1983–1992. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Song Z, Wu Y, Yang J, Yang D and Fang X:
Progress in the treatment of advanced gastric cancer. Tumour Biol.
Jul 3–2017.doi: org/10.1177/1010428317714626. View Article : Google Scholar
|
|
21
|
Ilson DH: Advances in the treatment of
gastric cancer. Curr Opin Gastroenterol. 34:465–468. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hu Y, Huang C, Sun Y, Su X, Cao H, Hu J,
Xue Y, Suo J, Tao K, He X, et al: Morbidity and mortality of
laparoscopic versus open D2 distal gastrectomy for advanced gastric
cancer: A Randomized Controlled Trial. J Clin Oncol. 34:1350–1357.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tang W, Fu K, Sun H, Rong D, Wang H and
Cao H: CircRNA microarray profiling identifies a novel circulating
biomarker for detection of gastric cancer. Mol Cancer. 17:1372018.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gu W, Sun Y, Zheng X, Ma J, Hu XY, Gao T
and Hu MJ: Identification of gastric cancer-related circular RNA
through microarray analysis and bioinformatics analysis. BioMed Res
Int. 2018:23816802018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li P, Chen S, Chen H, Mo X, Li T, Shao Y,
Xiao B and Guo J: Using circular RNA as a novel type of biomarker
in the screening of gastric cancer. Clin Chim Acta. 444:132–136.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Peng N, Shi L, Zhang Q, Hu Y, Wang N and
Ye H: Microarray profiling of circular RNAs in human papillary
thyroid carcinoma. PLoS One. 12:e01702872017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Qian Y, Yan Y, Lu H, Zhou T, Lv M, Fang C,
Hou J, Li W, Chen X, Sun H, et al: Celastrus orbiculatus extracts
inhibit the metastasis through attenuating PI3K/Akt/mTOR signaling
pathway in human gastric cancer. Anticancer Agents Med Chem.
19:1754–1761. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang H, Pan YZ, Cheung M, Cao M, Yu C,
Chen L, Zhan L, He ZW and Sun CY: LAMB3 mediates apoptotic,
proliferative, invasive, and metastatic behaviors in pancreatic
cancer by regulating the PI3K/Akt signaling pathway. Cell Death
Dis. 10:2302019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li M, Li Y and Yu M: CircRNA ZNF609
Knockdown Suppresses Cell Growth via Modulating miR-188/ELF2 Axis
in Nasopharyngeal Carcinoma. Onco Targets Ther. 13:2399–2409. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xin J, Zhang XY, Sun DK, Tian LQ and Xu P:
Up-regulated circular RNA hsa_circ_0067934 contributes to
glioblastoma progression through activating PI3K-AKT pathway. Eur
Rev Med Pharmacol Sci. 23:3447–3454. 2019.PubMed/NCBI
|
|
31
|
Chen T, Shao S, Li W, Liu Y and Cao Y: The
circular RNA hsa-circ-0072309 plays anti-tumour roles by sponging
miR-100 through the deactivation of PI3K/AKT and mTOR pathways in
the renal carcinoma cell lines. Artif Cells Nanomed Biotechnol.
47:3638–3648. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Peng YK, Pu K, Su HX, Zhang J, Zheng Y, Ji
R, Guo QH, Wang YP, Guan QL and Zhou YN: Circular RNA
hsa_circ_0010882 promotes the progression of gastric cancer via
regulation of the PI3K/Akt/mTOR signaling pathway. Eur Rev Med
Pharmacol Sci. 24:1142–1151. 2020.PubMed/NCBI
|
|
33
|
Wang Y, Cao Z, Wang L, Liu S and Cai J:
Downregulation of microRNA-142-3p and its tumor suppressor role in
gastric cancer. Oncol Lett. 15:8172–8180. 2018.PubMed/NCBI
|
|
34
|
Ebert MS and Sharp PA: MicroRNA sponges:
Progress and possibilities. RNA. 16:2043–2050. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang Q, Miao Y, Fu Q, Hu H, Chen H, Zeng
A, Jin Y, Jiang Y, Qian L, Wu L, et al: CircRNACCDC66 regulates
cisplatin resistance in gastric cancer via the miR-618/BCL2 axis.
Biochem Biophys Res Commun. 526:713–720. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Troschel FM, Böhly N, Borrmann K, Braun T,
Schwickert A, Kiesel L, Eich HT, Götte M and Greve B: miR-142-3p
attenuates breast cancer stem cell characteristics and decreases
radioresistance in vitro. Tumour Biol. Aug 9–2018.(Epub ahead of
print). doi: 10.1177/1010428318791887. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhu X, Ma SP, Yang D, Liu Y, Wang YP, Lin
T, Li Y, Yang S, Zhang W and Wang X: miR-142-3p suppresses cell
growth by targeting CDK4 in colorectal cancer. Cell Physiol
Biochem. 51:1969–1981. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tan YF, Chen ZY, Wang L, Wang M and Liu
XH: MiR-142-3p functions as an oncogene in prostate cancer by
targeting FOXO1. J Cancer. 11:1614–1624. 2020. View Article : Google Scholar : PubMed/NCBI
|
